NCT00856414View on ClinicalTrials.gov

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Skin Aging
Interventions
BIOLOGICAL

botulinum toxin Type A

20U, up to two injections administered intramuscularly into the glabella (2 in each side of the corrugators and 1 in the procerus)

Trial Locations (2)

Unknown

West Palm Beach

Livonia

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00856414 - Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines | Biotech Hunter | Biotech Hunter